| scholarly article | Q13442814 |
| P2093 | author name string | Rodolfo Alvarez-Sala | |
| Carlos Zamarrón | |||
| Luis Valdés Cuadrado | |||
| P2860 | cites work | Close relation of endothelial function in the human coronary and peripheral circulations | Q71827302 |
| Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome | Q72629348 | ||
| Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves | Q73375022 | ||
| The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease | Q73675027 | ||
| Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease | Q74150664 | ||
| Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease | Q74465227 | ||
| Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies? | Q79949011 | ||
| Endothelial dysfunction in diabetes mellitus | Q80505490 | ||
| Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk | Q81826825 | ||
| Cardiovascular risk factors and mortality in patients with coronary heart disease | Q82296894 | ||
| Ghrelin and cardiovascular diseases | Q83007122 | ||
| Ghrelin modulates baroreflex-regulation of sympathetic vasomotor tone in healthy humans | Q83857499 | ||
| Sleep in chronic obstructive lung disease. | Q49031028 | ||
| Abnormal breathing patterns during sleep in diabetes. | Q49045100 | ||
| An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. | Q50229530 | ||
| Oscillatory pressure wave transmission from the upper airway to the carotid artery. | Q50933685 | ||
| Sleep-disordered breathing in older adults: is it a condition distinct from that in middle-aged adults? | Q50995196 | ||
| Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. | Q52312223 | ||
| Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. | Q54619726 | ||
| Increased platelet activation in patients with stable and acute exacerbation of COPD | Q58316988 | ||
| Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk | Q58316999 | ||
| Systemic Effects of Chronic Obstructive Pulmonary Disease | Q58840535 | ||
| Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease | Q60155038 | ||
| Obstructive Sleep Apnea and Atherosclerosis | Q61386195 | ||
| Slow breathing reduces sympathoexcitation in COPD | Q66829301 | ||
| Pathogenesis of upper airway occlusion during sleep | Q67355497 | ||
| Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension | Q71089889 | ||
| Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome | Q24599312 | ||
| Heavy snoring as a cause of carotid artery atherosclerosis | Q24647982 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients | Q28267419 | ||
| The endocrine function of adipose tissue: an update | Q28305131 | ||
| Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake | Q28570572 | ||
| Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
| The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
| Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study | Q29615583 | ||
| Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method | Q30455065 | ||
| Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials | Q30954736 | ||
| Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study | Q32155167 | ||
| Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease | Q33194719 | ||
| Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement | Q33400212 | ||
| Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities | Q33586766 | ||
| The spectrum of sleep-disordered breathing. | Q33695502 | ||
| Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing | Q33700731 | ||
| Vascular inflammation in obesity and sleep apnea | Q33829997 | ||
| Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea | Q33916216 | ||
| Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea | Q33988152 | ||
| Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients | Q34122262 | ||
| Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment | Q34227249 | ||
| Intermittent hypoxia: cell to system | Q34336970 | ||
| Snoring-related energy transmission to the carotid artery in rabbits. | Q34491060 | ||
| Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea | Q34535079 | ||
| Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome | Q44878977 | ||
| Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. | Q44884510 | ||
| Serum-insulin in essential hypertension and in peripheral vascular disease | Q44899325 | ||
| C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study | Q44985580 | ||
| Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver | Q45197559 | ||
| Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome | Q45894281 | ||
| Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. | Q46055084 | ||
| The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. | Q46121404 | ||
| Endothelial function predicts progression of carotid intima-media thickness | Q46127803 | ||
| Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea | Q46173029 | ||
| Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome | Q46266518 | ||
| Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea | Q46460378 | ||
| CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. | Q46570670 | ||
| Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension | Q46710321 | ||
| Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome | Q46736144 | ||
| Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. | Q46842079 | ||
| Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance | Q46887042 | ||
| Delayed neutrophil apoptosis in patients with sleep apnea | Q46897531 | ||
| Antioxidant vitamin C improves endothelial function in obstructive sleep apnea | Q46913805 | ||
| Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count | Q46954252 | ||
| Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha | Q46968793 | ||
| Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome | Q47209562 | ||
| Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea | Q47234433 | ||
| Excess weight and sleep-disordered breathing | Q47368959 | ||
| Relationship between obstructive sleep apnea and diurnal leptin rhythms | Q47655571 | ||
| Influence of treatment on leptin levels in patients with obstructive sleep apnoea | Q47767046 | ||
| Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. | Q47830194 | ||
| Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome | Q47850181 | ||
| Pulmonary haemodynamics in patients with OSAS or an overlap syndrome | Q47858181 | ||
| Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea | Q47882764 | ||
| Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment | Q47912911 | ||
| Resistin levels in patients with obstructive sleep apnoea syndrome--the link to subclinical inflammation? | Q47937262 | ||
| Association of metabolic factors with high-sensitivity C-reactive protein in patients with sleep-disordered breathing | Q48218768 | ||
| Plasma selectins in patients with obstructive sleep apnea. | Q48231179 | ||
| CPAP for the metabolic syndrome in patients with obstructive sleep apnea | Q48269770 | ||
| Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. | Q48284778 | ||
| Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial | Q48288725 | ||
| Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. | Q48290022 | ||
| Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans | Q48293764 | ||
| Obstructive sleep apnoea and metabolic impairment in severe obesity. | Q48300689 | ||
| The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea | Q48303362 | ||
| Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity | Q48305422 | ||
| Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure | Q48310770 | ||
| Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients | Q48314979 | ||
| Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy | Q48317433 | ||
| Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea | Q48324307 | ||
| Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue | Q48327719 | ||
| C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy | Q48349226 | ||
| Mesenchymal stem cells reduce inflammation in a rat model of obstructive sleep apnea. | Q48351451 | ||
| Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels | Q48353131 | ||
| Relationship between muscle sympathetic nerve activity and plasma leptin concentration | Q38344417 | ||
| Sympathetic activation by hypoxia and hypercapnia--implications for sleep apnea | Q39571521 | ||
| Prevalence of Sleep-disordered Breathing and Sleep Apnea in Middle-aged Urban Indian Men | Q39668765 | ||
| Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India | Q39762160 | ||
| Sleep-disordered breathing in a middle-aged and older Polish urban population | Q39834583 | ||
| Repeated inspiratory occlusions in anesthetized rats acutely increase blood coagulability as assessed by thromboelastography | Q39907213 | ||
| Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD. | Q40043314 | ||
| Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome | Q40166547 | ||
| Are breathing disturbances in elderly equivalent to sleep apnea syndrome? | Q40756129 | ||
| Heavy snorer disease: from snoring to the sleep apnea syndrome--an overview | Q41650201 | ||
| Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease | Q42487208 | ||
| Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome | Q42501131 | ||
| Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy | Q42512473 | ||
| Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes | Q42805075 | ||
| Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome | Q43105664 | ||
| Adipokines in children with obstructive sleep apnea and the effects of treatment | Q43214550 | ||
| Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea | Q43510158 | ||
| Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. | Q43545269 | ||
| Differential vascular sensitivity to luminally and adventitially applied endothelin-1. | Q43565561 | ||
| Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity | Q43678606 | ||
| Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study | Q43690992 | ||
| Evidence for lipid peroxidation in obstructive sleep apnea | Q43800410 | ||
| Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. | Q43809017 | ||
| Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. | Q44117488 | ||
| Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. | Q44133831 | ||
| Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study | Q44333600 | ||
| Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea | Q44387214 | ||
| Intermittent hypoxia increases insulin resistance in genetically obese mice | Q44524266 | ||
| Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables | Q44550009 | ||
| Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality | Q44599748 | ||
| 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. | Q44615125 | ||
| Association between polysomnographic measures of disrupted sleep and prothrombotic factors | Q44701329 | ||
| Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. | Q44854580 | ||
| Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q34545044 | ||
| Adiponectin in health and disease | Q34613068 | ||
| Tissue vibration induces carotid artery endothelial dysfunction: a mechanism linking snoring and carotid atherosclerosis? | Q34997412 | ||
| Relationship between sleep apnea, fat distribution, and insulin resistance in obese children | Q35042263 | ||
| The association among lipoprotein-associated phospholipase A2 levels, total antioxidant capacity and arousal in male patients with OSA. | Q35057921 | ||
| Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome | Q35092244 | ||
| Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state | Q35131027 | ||
| Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance | Q35161362 | ||
| Nitric oxide (NO) and obstructive sleep apnea (OSA). | Q35178118 | ||
| Decreased slow wave sleep increases risk of developing hypertension in elderly men | Q35223298 | ||
| Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome | Q35535129 | ||
| Obesity, Sleep Apnea, and Hypertension | Q35580802 | ||
| Sympathetic neural mechanisms in obstructive sleep apnea. | Q35764596 | ||
| Resistin: functional roles and therapeutic considerations for cardiovascular disease | Q35859749 | ||
| Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. | Q35995551 | ||
| Sleep apnea is a manifestation of the metabolic syndrome | Q36127164 | ||
| Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
| Prevalence of obstructive sleep apnoea in men with type 2 diabetes | Q36237929 | ||
| Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). | Q36308003 | ||
| Neurohumoral activation as a link to systemic manifestations of chronic lung disease | Q36320236 | ||
| Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea | Q36518032 | ||
| Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment | Q36555722 | ||
| Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities | Q36696149 | ||
| Adiponectin as an anti-inflammatory factor | Q36753830 | ||
| Effects of intermittent hypoxia on the heart | Q36825899 | ||
| Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. | Q36844684 | ||
| Metabolic syndrome: from global epidemiology to individualized medicine | Q36939259 | ||
| The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition | Q36990311 | ||
| Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches | Q37077157 | ||
| Sleep duration and biomarkers of inflammation | Q37083153 | ||
| Cardiovascular injury and repair in chronic obstructive pulmonary disease | Q37098445 | ||
| Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome | Q37146144 | ||
| Obstructive sleep apnea of obese adults: pathophysiology and perioperative airway management | Q37417055 | ||
| Chronic obstructive pulmonary disease and obstructive sleep apnea. Association, consequences and treatment | Q37857197 | ||
| Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease | Q37872566 | ||
| Endothelial progenitor cells in cardiovascular disease and hypoxia--potential implications to obstructive sleep apnea | Q37894942 | ||
| 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans | Q48355419 | ||
| Dietary and physical activity patterns in children with obstructive sleep apnea | Q48372021 | ||
| Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea | Q48395056 | ||
| Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. | Q48396369 | ||
| Reticulocytes in untreated obstructive sleep apnoea. | Q48416313 | ||
| Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. | Q48422732 | ||
| Continuous positive nasal airway pressure decreases levels of serum amyloid A and improves autonomic function in obstructive sleep apnea syndrome. | Q48430826 | ||
| Resistin is closely related to systemic inflammation in obstructive sleep apnea. | Q48431389 | ||
| Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. | Q48439260 | ||
| Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. | Q48453630 | ||
| Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. | Q48455753 | ||
| Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. | Q48478110 | ||
| Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. | Q48479050 | ||
| Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. | Q48481292 | ||
| Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk. | Q48487064 | ||
| Reduced levels of adiponectin in sleep apnea syndrome. | Q48488364 | ||
| Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. | Q48491594 | ||
| Plasma levels of vascular endothelial markers in obstructive sleep apnea. | Q48504520 | ||
| Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. | Q48506319 | ||
| Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure. | Q48507311 | ||
| Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. | Q48516715 | ||
| Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. | Q48522609 | ||
| Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. | Q48525924 | ||
| Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. | Q48528105 | ||
| Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. | Q48559308 | ||
| Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. | Q48614785 | ||
| Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
| Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. | Q48616776 | ||
| Serum amyloid a in obstructive sleep apnea. | Q48619636 | ||
| Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. | Q48621102 | ||
| The association of the severity of obstructive sleep apnea with plasma leptin levels. | Q48627620 | ||
| Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. | Q48634373 | ||
| Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. | Q48643458 | ||
| A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. | Q48651105 | ||
| Elevated C-reactive protein in patients with obstructive sleep apnea. | Q48660954 | ||
| Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. | Q48662343 | ||
| Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. | Q48682155 | ||
| Role of endothelin in intermittent hypoxia-induced hypertension. | Q48701728 | ||
| Circulating endothelin-1 and obstructive sleep apnoea. | Q48708628 | ||
| Serum leptin and vascular risk factors in obstructive sleep apnea. | Q48713881 | ||
| Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. | Q48716348 | ||
| Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. | Q48727889 | ||
| Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. | Q48729153 | ||
| Marked sympathetic activation in patients with chronic respiratory failure. | Q48747332 | ||
| Effects of obstructive sleep apnea on endothelin-1 and blood pressure. | Q48768740 | ||
| The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. | Q48769862 | ||
| Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. | Q48801175 | ||
| Association of chronic obstructive pulmonary disease and sleep apnea syndrome. | Q48827347 | ||
| Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. | Q48829306 | ||
| Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. | Q48905397 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pathophysiology | Q1135939 |
| cardiovascular disease | Q389735 | ||
| obstructive sleep apnea | Q16606552 | ||
| P304 | page(s) | 521087 | |
| P577 | publication date | 2013-06-27 | |
| P1433 | published in | Pulmonary Medicine | Q26842234 |
| P1476 | title | Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome | |
| P478 | volume | 2013 |
| Q41710567 | Association of Fragmented QRS with Subclinical Left Ventricular Dysfunction in Patients with Obstructive Sleep Apnea. |
| Q55664644 | Early left ventricular systolic and diastolic dysfunction in patients with newly diagnosed obstructive sleep apnoea and normal left ventricular ejection fraction. |
| Q54116553 | Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway. |
| Q36320815 | High risk for obstructive sleep apnea in patients with acute myocardial infarction |
| Q35668765 | Non-alcoholic fatty liver disease - the heart of the matter |
| Q27692035 | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. |
| Q52564872 | Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention. |
| Q91794271 | Obstructive sleep apnea: Is it a biomarker of metabolic health in obesity |
| Q47759330 | Pulmonary hypertension and echocardiogram parameters in obstructive sleep apnea |
| Q92650087 | Relationship Between Sleep Apnea and Coronary Artery Calcium in Patients With Ischemic Stroke |
| Q33631801 | Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS). |
| Q92267246 | Repercussion of medium and long treatment period with continuous positive airways pressure therapy in heart rate variability of obstructive sleep apnea |
| Q92432242 | SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA |
| Q41677682 | Severity of childhood obstructive sleep apnea and hypertension improved after adenotonsillectomy |
| Q36640011 | Significance of vaspin in obstructive sleep apnea-hypopnea syndrome |
| Q40106347 | Sleep quality and adverse outcomes for patients with acute myocardial infarction. |
| Q41413311 | The addition of entropy-based regularity parameters improves sleep stage classification based on heart rate variability. |
| Q38853092 | The chronic syndromes after previous treatment of pituitary tumours |
| Q28081308 | The role of continuous positive airway pressure in blood pressure control for patients with obstructive sleep apnea and hypertension: a meta-analysis of randomized controlled trials |
Search more.